Peptides

Items 2001-2050 of 3079

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Antimicrobial Peptide

    Pardaxin P5 is an antimicrobial peptide targeting bacterial membranes. It demonstrates significant inhibitory activity against Escherichia coli, with a minimum inhibitory concentration (MIC) of 13 μM. This compound is valuable for research applications focusing on the development of novel antimicrobial agents and the study of peptide interactions with bacterial membranes.
  2. Antimicrobial Peptide

    DFTamP1 is an antimicrobial peptide that demonstrates potent activity against Staphylococcus aureus USA300, with a minimum inhibitory concentration (MIC) of 3.1 μM. This compound is primarily utilized in research focusing on antimicrobial mechanisms and the development of novel therapeutic agents targeting bacterial infections. Its efficacy in inhibiting S. aureus provides valuable insights for studies in microbiology and infectious disease.
  3. Dipeptide

    Arg-Trp is a dipeptide composed of the amino acids arginine and tryptophan, known for its potential antibacterial properties. Research indicates that analogues of Arg-Trp, specifically those modified with octyl esters, exhibit significant antibacterial activity. This makes Arg-Trp and its derivatives valuable for investigations in antimicrobial research and the development of new therapeutic agents.
  4. Antimicrobial Peptide

    FLGFVGQALNALLGKL-NH2 is an antimicrobial peptide derived from frog sources, exhibiting potent activity against Staphylococcus aureus ATCC 29213 with a minimum inhibitory concentration (MIC) of 32 μM. This peptide serves as a valuable tool in the study of antimicrobial properties and the mechanisms of resistance in bacterial pathogens, making it suitable for research applications in microbiology and drug development.
  5. Antimicrobial Peptide

    SAAP Fraction 3 is an antimicrobial peptide that exhibits activity against Porphyromonas haemolytica in Zn-saline buffer. This compound is primarily utilized in research focused on antimicrobial resistance and peptide-based therapies. Its efficacy makes it a valuable tool for studying the mechanisms of microbial inhibition and developing novel antimicrobial agents.
  6. Antimicrobial Peptide

    Maximin H3 is an antimicrobial peptide targeting a broad spectrum of pathogens. Derived from the skin secretions of the Chinese red belly toad (Bombina maxima), it demonstrates significant antibacterial and antifungal activities. Maximin H3 is effective against Escherichia coli, Staphylococcus aureus, Bacillus pyocyaneus, and Candida albicans, with minimum inhibitory concentration (MIC) values of 20, 10, 20, and 5 μg/ml, respectively. This peptide is valuable for research in antimicrobial therapies and the study of host-defense mechanisms.
  7. Antimicrobial Peptide

    Bombinin H2 is an antimicrobial peptide sourced from the skin of the European fire-bellied toad, Bombina variegata. This peptide exhibits potent antimicrobial activity against a range of bacterial and fungal pathogens, making it a valuable tool in microbiological studies. Its unique structure and mechanism of action also make it suitable for research into peptide therapeutics and the development of novel antimicrobial agents.
  8. Antimicrobial Peptide

    Anoplin is an antimicrobial peptide derived from the venom of the solitary wasp Anoplius samariensis, targeting bacterial membranes. It demonstrates potent antimicrobial activity against a diverse range of bacteria, including both gram-positive and gram-negative strains. This unique peptide has potential applications in the development of novel antibiotic therapies.
  9. Antimicrobial Peptide

    Polyphemusin I is a natural antimicrobial peptide targeting bacterial membranes. It exhibits potent antimicrobial activity against both Gram-negative and Gram-positive bacteria, making it a valuable tool in antimicrobial research. Comprised of 18 amino acids, Polyphemusin I is characterized by its amphiphilic structure and stabilization via two disulfide bridges, which contribute to its effective interaction with microbial cells. This peptide can be utilized in studies assessing antibacterial mechanisms and developing new antimicrobial agents.
  10. Antimicrobial Peptide

    Cathelicidin-2 (chicken) is an antimicrobial peptide that exhibits strong bactericidal and fungicidal properties. It is particularly effective against chicken-specific Salmonella isolates, making it a valuable tool in poultry health research. This peptide can be utilized in studies focused on antimicrobial resistance and the development of novel therapeutic strategies for avian diseases.
  11. Antimicrobial Peptide

    LS-BF1 is a cationic antimicrobial peptide that operates primarily through cell membrane disruption. This compound exhibits a broad spectrum of antibacterial activity, effectively targeting difficult pathogens such as those in the ESKAPE group. Additionally, LS-BF1 has demonstrated significant in vivo efficacy in eradicating bacteria in mouse infection models, making it a valuable tool for research in antimicrobial therapies.
  12. Peptide Segment

    Lactocin 705β is a peptide segment that plays a crucial role in the assembly of class IIb bacteriocins, specifically Lactocin 705, in conjunction with Lac705α. While Lactocin 705β does not exhibit antibacterial activity in isolation, it is valuable for studying the mechanisms of bacterial infections and the functional characterization of bacteriocin systems. This reagent is particularly relevant for researchers exploring peptide-based antimicrobial strategies.
  13. Antimicrobial Peptide

    Tilapia piscidin 3 is an antimicrobial peptide that exhibits significant antibacterial activity against both gram-positive and gram-negative bacteria, with minimum inhibitory concentrations (MIC) of 2.44 μg/mL for Vibrio vulnificus, 2.44 μg/mL for Vibrio alginolyticus, 9.78 μg/mL for Streptococcus agalactiae, 19.55 μg/mL for Enterococcus faecalis, and 0.61 μg/mL for another strain of Streptococcus agalactiae. Additionally, this peptide demonstrates hemolytic activity in fish red blood cells. Its potent antimicrobial properties make it valuable for research in microbial resistance and the development of new therapeutic agents.
  14. Cationic Peptide

    Bactenecin 7 is a cationic peptide that exhibits antibacterial activity specifically against Enterobacter cloacae, demonstrating minimum inhibitory concentrations (MICs) ranging from 25 to 200 μg/ml. This peptide is valuable in research applications focused on microbial resistance mechanisms and the development of novel antimicrobial therapies. Its ability to disrupt bacterial membrane integrity makes it a candidate for studies aiming to enhance the effectiveness of existing antibiotics or discover new antibacterial agents.
  15. Lipopeptide Antibiotic

    Friulimicin D is a lipopeptide antibiotic derived from the actinomycete Actinoplanes friuliensis. It demonstrates significant antibacterial activity against a range of Gram-positive bacteria. Research applications include the study of bacterial resistance mechanisms and the potential development of novel antimicrobial therapies.
  16. Antimicrobial Peptide

    BING is an antimicrobial peptide derived from Japanese medaka fish, targeting pathogenic bacteria with a broad-spectrum antibacterial activity, including effectiveness against drug-resistant strains. Its mechanism involves the deregulation of periplasmic peptidyl-prolyl isomerases in gram-negative bacteria, leading to a reduction in cpxR RNA levels, which are essential for antimicrobial resistance development. BING is a valuable tool for research in antimicrobial resistance and the development of novel therapeutic strategies.
  17. Antimicrobial Peptide

    Brevinin-1E is an antimicrobial peptide derived from the skin secretions of Rana esculenta, demonstrating significant antimicrobial activity against various bacterial strains. This peptide acts by disrupting microbial cell membranes, leading to cell lysis and death. Brevinin-1E is primarily utilized in research applications focusing on antimicrobial resistance mechanisms, peptide therapeutics, and the development of novel antimicrobial agents.
  18. Antimicrobial Peptide

    BMAP-27 is an antimicrobial peptide that disrupts the membrane integrity of microorganisms. It exhibits significant antibacterial and anticancer activity due to its ability to permeate cell membranes. This compound is valuable for research applications focused on microbiology and cancer biology, providing insights into membrane-targeting therapies.
  19. Antimicrobial Peptide

    Bombolitin IV is an antimicrobial peptide derived from bumblebee venom, known for its ability to disrupt membrane integrity. This compound exhibits potent lytic activity against erythrocytes and liposomes, making it a valuable tool for studying membrane-targeting mechanisms. Its applications extend to antimicrobial research, providing insights into new therapeutic strategies against resistant pathogens.
  20. Bioactive Peptide

    C18G is a bioactive peptide that exhibits antibacterial properties. Derived from human platelet factor IV, this synthetic α-helical peptide is specifically active against Salmonella. C18G's capacity to target bacterial infections makes it valuable for research in microbiology and therapeutic applications aimed at combating antibiotic-resistant strains.
  21. P1

    Antimicrobial Peptide

    P1 is a broad-spectrum antimicrobial peptide that exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria. It demonstrates efficacy against challenging pathogens, including Bacillus anthracis spores and Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae. This reagent is suitable for applications in microbiological research and the development of novel antimicrobial therapies.
  22. Immunogenic Peptide

    MOG(35-55) amide is an immunogenic peptide derived from the myelin oligodendrocyte glycoprotein (MOG), specifically the terminal amidation form of the 35-55 fragment. This peptide is crucial for the induction of experimental autoimmune encephalomyelitis (EAE), serving as a valuable tool in multiple sclerosis research. It aids in studying the mechanisms of autoimmune responses and the development of potential therapeutic strategies.
  23. Neuropeptide

    α-CGRP (mouse, rat) is a neuropeptide that primarily targets the neuromuscular junction and functions as a potent vasodilator. It is known to induce a decrease in blood pressure and an increase in heart rate upon peripheral administration, and it also promotes relaxation of colonic smooth muscle. This peptide is valuable for research applications in cardiovascular studies, pro-inflammatory responses, migraine pathophysiology, and metabolic processes.
  24. Calcitonin Peptide

    β-CGRP, human is a member of the calcitonin peptide family and functions through binding to the calcitonin-receptor-like receptor (CRLR) in conjunction with receptor-activity-modifying proteins (RAMPs). It exhibits high affinity, with IC50 values of 1 nM for the CRLR/RAMP1 complex and 300 nM for the CRLR/RAMP2 complex in cellular assays. This peptide is crucial for research in pain modulation, migraine mechanisms, and neurobiological studies.
  25. CGRP Receptor Activator

    Calcitonin Gene Related Peptide II (rat) is a CGRP receptor activator that functions as a potent and enduring vasodilator. It plays a crucial role in the regulation of vascular tone and blood pressure. This peptide is utilized in research on cardiovascular diseases, aiding in the exploration of therapeutic strategies for conditions such as hypertension and vascular dysfunction.
  26. Bioactive Peptide

    Biotin-Gastrin-1, human (1-17) is a bioactive peptide that functions through the gastrin receptor. It plays a critical role in stimulating gastric acid secretion and promoting gastrointestinal motility. This compound is invaluable for research applications involving digestive physiology, cancer biology, and peptide signaling pathways.
  27. Peptide Hormone

    Gastrin I (Rat Gastrin-17) is a peptide hormone that primarily stimulates gastric acid secretion. It plays a crucial role in digestive processes by promoting the production of gastric acid, thereby facilitating digestion and nutrient absorption. This compound is essential for research applications related to gastrointestinal physiology and peptic disorders.
  28. CCK Derivative

    Cholecystokinin Octapeptide, desulfated TFA is a synthetic derivative of the endogenous hormone cholecystokinin (CCK), which primarily targets CCK receptors. This peptide exhibits key biological activities related to digestion and satiety regulation, making it valuable in studies of gastrointestinal physiology and appetite control. It is frequently utilized in research applications investigating the role of CCK in various biological processes, including pancreatic enzyme secretion and gastric motility.
  29. Bioactive Peptide

    [Lys3]-Bombesin is a bioactive peptide that targets the gastrin-releasing peptide receptor (GRPR). Its primary application includes PET imaging for detecting GRPR-positive prostate cancer, facilitating non-invasive tumor visualization. Additionally, [Lys3]-Bombesin can be utilized in immunoconjugates with monoclonal antibodies to selectively induce CD64-dependent lysis of small cell carcinoma by monocytes and neutrophils, providing insights into targeted cancer therapies.
  30. Peptide Hormone

    CCK (26-31) sulfated is a peptide hormone fragment that plays a crucial role in gastrointestinal function and neuroendocrine signaling. This bioactive peptide is involved in stimulating digestive processes, modulating appetite, and influencing anxiety-related behavior. Research applications include studies on gut-brain interactions, appetite regulation, and the pharmacological effects of peptide hormones in both physiological and pathological contexts.
  31. C-terminal heptapeptide of CCK

    CCK (27-33) is the C-terminal heptapeptide derived from cholecystokinin (CCK), which primarily targets CCK receptors. This peptide plays a significant role in stimulating gallbladder contraction and promoting pancreatic enzyme secretion, making it crucial for investigating digestive processes. CCK (27-33) is utilized in research applications focusing on gastrointestinal physiology and receptor signaling pathways.
  32. Acidic Peptide

    Minigastrin is an acidic peptide that primarily targets the gastrin receptor. It plays a crucial role in stimulating gastric acid secretion and is utilized in research applications involving gastrointestinal physiology and pathology. Minigastrin can be employed to investigate peptide-peptide interactions and their implications in digestive disorders.
  33. Human Gastrin I Peptide

    Gastrin I (1-14), human is the 1-14 fragment of the human gastrin I peptide, which acts as an endogenous gastrointestinal hormone. This peptide plays a crucial role in regulating gastric acid secretion, influencing digestive processes. It is predominantly used in research applications focused on gastrointestinal physiology and peptic disorders.
  34. Neuropeptide

    Neuropeptide SF (human) serves as a neuropeptide that primarily targets the regulation of paraventricular corticotrophin-releasing hormone (CRH) release. This neuropeptide enhances the release of adrenocorticotropic hormone (ACTH) and increases plasma corticosterone levels, playing a crucial role in modulating circadian functions, including motor center activity and the hypothalamic-pituitary-adrenal (HPA) axis. It is useful for research applications focused on stress response and circadian rhythm regulation.
  35. Neuropeptide

    Neuropeptide SF (human) acetate is a neuropeptide that targets the paraventricular nucleus to enhance corticotrophin-releasing hormone (CRH) release. It is known to elevate plasma levels of adrenocorticotropic hormone (ACTH) and corticosterone, playing a vital role in the regulation of circadian functions, including motor activity and the hypothalamic-pituitary-adrenal (HPA) axis. This reagent is useful in research applications related to stress response, endocrine signaling, and neuroendocrine regulation.
  36. CRH Receptor Ligand

    Stresscopin-related peptide (human) is a specific ligand for the corticotropin-releasing hormone (CRH) receptor type 2. It is known to suppress food intake, delay gastric emptying, and reduce heat-induced edema. This peptide plays a crucial role in maintaining homeostasis following stress and is valuable for research into stress-related disorders and physiological responses.
  37. CXCR4 Inhibitor

    Peptide R is a cyclic peptide that functions as a specific antagonist of the CXCR4 receptor. It demonstrates significant efficacy in remodeling tumor stroma, making it a valuable tool for tumor research. Its ability to modulate the tumor microenvironment highlights its potential applications in cancer therapy and investigation into tumor progression mechanisms.
  38. peptide

    Polyphemusin II-Derived Peptide (T140) is a potent CXCR4 inhibitor that effectively blocks HIV-1 entry into host cells. Its mechanism involves disrupting the interaction between CXCR4 and the HIV-1 envelope glycoprotein, offering a targeted approach to HIV research. Additionally, T140 has been shown to inhibit the binding of the anti-CXCR4 monoclonal antibody (12G5) to its receptor, making it a valuable tool for studying CXCR4-related pathways and potential therapeutic interventions in viral infections.
  39. Radiolabeled Peptide

    Pentixather is a radiolabeled peptide that specifically targets the CXCR4 receptor. By interfering with the CXCR4/CXCL12 signaling axis, Pentixather disrupts the interaction between leukemic cells and the bone marrow microenvironment, thereby promoting the release of leukemic cells from the protective niche and increasing their sensitivity to therapeutics. This compound is valuable for research applications in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
  40. apoE-mimetic Peptide

    COG112 is an antennapedia-linked apoE-mimetic peptide that targets inflammatory pathways. It effectively attenuates nitric oxide production and inhibits the expression of CXC chemokines such as KC and MIP-2. Additionally, COG112 reduces the nuclear translocation of NF-κB and inhibits the phosphorylation of IκB-α, thereby preventing its degradation. This peptide is valuable for research applications focused on modulating inflammatory responses, particularly in the context of Citrobacter rodentium infection.
  41. Inflammatory Peptide

    Peptide 78 is an inflammatory peptide that functions as a chemotactic cytokine, belonging to the IL-8 or C-X-C chemokine supergene family. This 78 amino acid protein is essential for the recruitment of neutrophils to sites of inflammation, particularly in rheumatoid arthritis (RA) pathology. Its role in promoting neutrophil migration makes Peptide 78 a valuable tool for research into inflammatory diseases and immune responses.
  42. Secretoneurin Peptide Fragment

    Secretoneurin, rat, is a 33-amino acid polypeptide derived from the proteolytic processing of secretogranin II (SgII). This peptide plays a significant role in neuropharmacology by stimulating dopamine release in the rat striatum, both in vivo and in vitro. Additionally, Secretoneurin exhibits a potent chemotactic effect on monocytes and eosinophils, while showing no significant activity against granulocytes. This makes it valuable for research applications focused on neurobiology and immune response mechanisms.
  43. HIV Inhibitor

    (D-Ala)-Peptide T is an octapeptide that acts as an HIV inhibitor by targeting the HIV-1 envelope glycoprotein gp120. This compound has been shown to release chemokines and protect against neuronal death induced by gp120. It is a valuable reagent for research into infectious diseases and neurological disorders, particularly AIDS-related dementia.
  44. Polypeptide

    HIV-2 Peptide is a polypeptide utilized in research focusing on HIV-2. It serves as a valuable tool for protein interaction studies, functional analysis, and epitope screening, particularly in the context of agent research and development. This peptide facilitates the understanding of immune responses and the development of therapeutic strategies related to HIV-2 infections.
  45. Peptide

    (Cys47)-HIV-1 tat Protein (47-57) is a peptide known for its ability to facilitate membrane translocation. This peptide can be utilized to modify the surface of magnetic pharmaceuticals, significantly enhancing their uptake into target cells. It serves as a valuable tool in drug delivery systems and cellular uptake studies in research applications.
  46. Cell-Penetrating Peptide

    TAT (47-57), FAM-labeled is a cell-penetrating peptide (CPP) that enhances the delivery of therapeutic agents into cells. This peptide facilitates the transport of various cargoes, making it a valuable tool for intracellular drug delivery studies. Its FAM labeling allows for easy monitoring and tracking in biological systems, enabling researchers to explore applications in drug formulation and cellular uptake mechanisms.
  47. Antimicrobial Peptides

    Siamycin III is an antimicrobial peptide that exhibits activity against HIV-1. It is primarily used in research applications focusing on antiviral mechanisms and the development of therapies targeting viral infections. The compound's ability to interfere with viral replication makes it a valuable tool for studies in HIV-1 biology and treatment strategies.
  48. HIV Entry Inhibitor

    T-peptide is an HIV entry inhibitor that functions as a Tuftsin analog, effectively targeting HIV infection. This compound is known to mitigate cellular immunosuppression and enhance survival rates in septic mouse models. Additionally, T-peptide demonstrates the ability to inhibit the growth of residual tumor cells following surgical resection, making it a valuable tool for oncological and infectious disease research applications.
  49. HIV-1 gp120 Peptide

    Peptide T TFA is an octapeptide derived from the V2 region of the HIV-1 gp120 protein. It functions as a ligand for the CD4 receptor, effectively inhibiting the binding of HIV to this receptor. This compound is valuable in research applications focused on HIV-1 infection mechanisms and the development of potential therapeutic interventions.
  50. HIV Peptide Epitope

    HIV gp120 (318-327) is a peptide epitope derived from the C-terminal region of the HIV-1 strain IIIB envelope glycoprotein. This sequence, known as the I10 peptide, is involved in the immune response and is part of the V3 peptide epitope relevant for HIV vaccine research. Although HIV gp120 (318-327) does not contain the A2 anchor residues recognized by cytotoxic T lymphocytes, it possesses structural characteristics that facilitate promiscuous binding to A2, making it valuable for studying HIV immunogenicity and vaccine development.

Items 2001-2050 of 3079

Page
per page
Set Descending Direction